Published in Gastroenterology on August 01, 2002
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut (2013) 3.14
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91
How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology (2008) 1.56
Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut (2004) 1.55
A population-based twin study of functional somatic syndromes. Psychol Med (2008) 1.53
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci (2013) 1.52
Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int (2009) 1.46
Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol (2009) 1.43
Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol (2004) 1.43
Scintigraphic biomarkers for colonic dysmotility. Clin Pharmacol Ther (2010) 1.34
Familial aggregation of irritable bowel syndrome: a prospective study. Gut (2003) 1.33
The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci (2007) 1.32
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.19
Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.18
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management. J Neurogastroenterol Motil (2012) 1.12
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials (2012) 1.10
Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol (2010) 1.05
Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther (2006) 1.04
A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology (2008) 1.03
Pharmacology of serotonin: what a clinician should know. Gut (2004) 1.02
Changing face of irritable bowel syndrome. World J Gastroenterol (2006) 0.99
Genetics of irritable bowel syndrome. Am J Gastroenterol (2008) 0.98
Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol (2011) 0.98
Genetic determination of irritable bowel syndrome. World J Gastroenterol (2008) 0.97
Serotonin transporter and G protein beta 3 subunit gene polymorphisms in Greeks with irritable bowel syndrome. Dig Dis Sci (2011) 0.97
Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol (2004) 0.96
Updates on treatment of irritable bowel syndrome. World J Gastroenterol (2008) 0.94
Pharmacogenetics of low dose clonidine in irritable bowel syndrome. Neurogastroenterol Motil (2009) 0.91
Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol (2014) 0.89
Genetic contribution to motility disorders of the upper gastrointestinal tract. World J Gastrointest Pathophysiol (2013) 0.88
Drug development for the irritable bowel syndrome: current challenges and future perspectives. Front Pharmacol (2013) 0.88
IBS--review and what's new. MedGenMed (2006) 0.87
Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes (2009) 0.87
Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci (2009) 0.87
Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther (2015) 0.87
The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci (2012) 0.87
What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.85
Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome. Int J Womens Health (2010) 0.85
Is there a SERT-ain association with IBS? Gut (2004) 0.84
Autonomic testing in functional gastrointestinal disorders: implications of reproducible gastrointestinal complaints during tilt table testing. Gastroenterol Res Pract (2009) 0.83
Genes and irritable bowel syndrome: is there a link? Curr Gastroenterol Rep (2008) 0.82
Lessons Learnt from Post-Infectious IBS. Front Physiol (2011) 0.82
Genetic polymorphism in pathogenesis of irritable bowel syndrome. World J Gastroenterol (2014) 0.82
Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia. BMC Med Genet (2011) 0.81
Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats. Br J Pharmacol (2009) 0.79
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol (2017) 0.79
New paradigm for studying genetic contributions to irritable bowel syndrome. Dig Dis Sci (2012) 0.79
Polymorphism in the oxytocin promoter region in patients with lactase non-persistence is not related to symptoms. BMC Gastroenterol (2009) 0.79
Ramosetron in irritable bowel syndrome with diarrhea: new hope or the same old story? Clin Gastroenterol Hepatol (2014) 0.79
Genetic epidemiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.79
The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nat Rev Gastroenterol Hepatol (2012) 0.79
Pathophysiologic findings of irritable bowel syndrome in china. J Neurogastroenterol Motil (2012) 0.79
TPH gene polymorphisms are associated with disease perception and quality of life in women with irritable bowel syndrome. Biol Res Nurs (2012) 0.78
Irritable bowel syndrome: a review article. Middle East J Dig Dis (2010) 0.78
Abnormal gastric myoelectrical activity in postural tachycardia syndrome. Clin Auton Res (2012) 0.77
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Extra digestive manifestations of irritable bowel syndrome: intolerance to drugs? Dig Dis Sci (2007) 0.77
Of actors, bolting horses, and drops in oceans! Gut (2003) 0.76
Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"? J Neurosci Rural Pract (2016) 0.76
Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1. Neurogastroenterol Motil (2014) 0.76
Association of Serotonin Transporter Promoter Polymorphism (5HTTLPR) with Microscopic Colitis and Ulcerative Colitis: Time to Be AsSERTive? Dig Dis Sci (2015) 0.75
Irritable bowel syndrome genophenomics: correlation of serotonin-transporter polymorphisms and alosetron response. Pharmacogenomics J (2003) 0.75
The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D). Therap Adv Gastroenterol (2015) 0.75
AJG series: molecular biology for clinicians. Am J Gastroenterol (2009) 0.75
Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations? MedGenMed (2005) 0.75
Patterns of alternation in irritable bowel syndrome. Clujul Med (2016) 0.75
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum. World J Gastroenterol (2013) 0.75
Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol (2016) 0.75
Sp1- and Krüppel-like transcription factors. Genome Biol (2003) 5.42
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology (2007) 2.30
A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol (2006) 2.30
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol (2012) 2.13
Evidence for the existence of an HP1-mediated subcode within the histone code. Nat Cell Biol (2006) 2.11
Sin3: master scaffold and transcriptional corepressor. Biochim Biophys Acta (2009) 2.05
The Heterochromatin Protein 1 family. Genome Biol (2006) 2.05
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell (2005) 2.01
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 1.94
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.93
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol (2009) 1.87
The family feud: turning off Sp1 by Sp1-like KLF proteins. Biochem J (2005) 1.83
Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci U S A (2005) 1.59
Rtt106p is a histone chaperone involved in heterochromatin-mediated silencing. Proc Natl Acad Sci U S A (2005) 1.55
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology (2010) 1.53
Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring) (2009) 1.52
Basics of TGF-beta and pancreatic cancer. Pancreatology (2007) 1.42
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.39
Academic skills: focusing. Pancreatology (2007) 1.39
Gene transfer of cocaine hydrolase suppresses cardiovascular responses to cocaine in rats. Mol Pharmacol (2004) 1.36
Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology (2006) 1.35
An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation. EMBO J (2003) 1.34
Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J Clin Invest (2012) 1.33
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol (2011) 1.33
A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy (2008) 1.29
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology (2011) 1.22
Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J Biol Chem (2006) 1.21
Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2008) 1.19
Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology (2011) 1.17
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol (2004) 1.16
MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells. J Biol Chem (2009) 1.15
Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer. EMBO Mol Med (2012) 1.14
KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells. Gastroenterology (2004) 1.14
Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling. J Biol Chem (2008) 1.14
Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol (2003) 1.13
Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol (2009) 1.12
KLF11-mediated repression antagonizes Sp1/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. J Biol Chem (2004) 1.12
Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol (2002) 1.12
Pancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes. Pancreatology (2010) 1.11
Characterization of the CXCR4 signaling in pancreatic cancer cells. Int J Gastrointest Cancer (2006) 1.11
Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol (2005) 1.09
Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol (2003) 1.08
A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol (2003) 1.07
Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor. EMBO J (2002) 1.07
A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growth. Biochem J (2011) 1.07
Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus. J Biol Chem (2011) 1.06
Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas (2003) 1.06
Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am J Physiol Gastrointest Liver Physiol (2007) 1.05
Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol (2007) 1.04
A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology (2008) 1.03
Sequence-specific recruitment of heterochromatin protein 1 via interaction with Krüppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic diseases. J Biol Chem (2012) 1.03
Proteomic analysis of an immortalized mouse pancreatic stellate cell line identifies differentially-expressed proteins in activated vs nonproliferating cell states. J Proteome Res (2011) 1.02
Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis. J Biol Chem (2010) 1.02
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis. Cancer Lett (2012) 1.02
Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss. Proc Natl Acad Sci U S A (2005) 1.02
Successful implantation of HeartWare HVAD left ventricular assist device with concomitant ascending and sinus of valsalva aneurysms repair. J Artif Organs (2012) 1.02
KLF11 mediates PPARγ cerebrovascular protection in ischaemic stroke. Brain (2013) 1.01
ROCK-dependent and ROCK-independent control of cochlear outer hair cell electromotility. J Biol Chem (2003) 1.00
Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology (2009) 0.99
Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis (2002) 0.97
Solvent-induced differentiation of protein backbone hydrogen bonds in calmodulin. Protein Sci (2007) 0.97
Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death. Clin Cancer Res (2012) 0.97
Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression. J Biol Chem (2012) 0.96
IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation. J Clin Invest (2014) 0.96
Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS). J Proteomics (2011) 0.95
Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1. J Biol Chem (2006) 0.95
Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver. Am J Pathol (2008) 0.95
Calmodulin wraps around its binding domain in the plasma membrane Ca2+ pump anchored by a novel 18-1 motif. J Biol Chem (2009) 0.94
Krüppel-like factor 11 differentially couples to histone acetyltransferase and histone methyltransferase chromatin remodeling pathways to transcriptionally regulate dopamine D2 receptor in neuronal cells. J Biol Chem (2012) 0.93
Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology (2006) 0.93
MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression. PLoS One (2011) 0.93
Differential binding of Sin3 interacting repressor domains to the PAH2 domain of Sin3A. FEBS Lett (2003) 0.93
Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery. Ann Thorac Surg (2011) 0.92
Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. Am J Physiol Gastrointest Liver Physiol (2010) 0.91
The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer research. Curr Opin Gastroenterol (2008) 0.91
Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis. Gut (2013) 0.91
Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci (2012) 0.90
Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implications. J Gastrointest Cancer (2009) 0.90
Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol (2005) 0.90
Krüppel-like factor-11, a transcription factor involved in diabetes mellitus, suppresses endothelial cell activation via the nuclear factor-κB signaling pathway. Arterioscler Thromb Vasc Biol (2012) 0.89
Detailed structural-functional analysis of the Krüppel-like factor 16 (KLF16) transcription factor reveals novel mechanisms for silencing Sp/KLF sites involved in metabolism and endocrinology. J Biol Chem (2011) 0.88
A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function. J Biol Chem (2005) 0.88
A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity (Silver Spring) (2009) 0.87
HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol (2011) 0.87
Role for Krüppel-like transcription factor 11 in mesenchymal cell function and fibrosis. PLoS One (2013) 0.86
Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer. Am J Pathol (2013) 0.86
Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci (2010) 0.84
Krüppel-like factor 11 regulates the expression of metabolic genes via an evolutionarily conserved protein interaction domain functionally disrupted in maturity onset diabetes of the young. J Biol Chem (2013) 0.84
Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression. Epigenetics Chromatin (2013) 0.84